Overall rank by patents
#35,205
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C02F (Treatment OF Water, Waste Water, Sewage, OR Sludge).
The verdict
According to USPTO PatentsView, Enpress ranks #35,205 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R35205 · US Corporation #35,205 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Endocontrol (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Enpress · this assignee
49 score
3D Lighting… · lowest
7 score
What this shows Enpress's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Enpress LLC is a focused PatentsView assignee: 11 CPC subclasses with 57.1% of grants classified under C02F (Treatment OF Water, Waste Water, Sewage, OR Sludge). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2015. By volume, Enpress sits between Endocontrol and EON Reality, Inc..
Enpress LLC shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Endocontrol
7 patents
Endostream Medical Ltd.
7 patents
Enea Agenzia Nazionale PER LE Nuove Tecnologie, L'energia E LO Sviluppo Economico Sostenibile
7 patents
Energy Control Limited
7 patents
Enyo Pharma
7 patents
Enzymaster (NINGBO) Bio-engineering Co., Ltd.
7 patents
Eolas Therapeutics, Inc
7 patents
EON Reality, Inc.
7 patents
Enpress LLC
7 patents
What this shows Enpress holds 7 patents at rank #35,147, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,147 in granted patent volume.
Other assignees with the most granted patents in Enpress's primary technology class.
Enpress's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2017 | 1 | 14.3% |
| 2019 | 1 | 14.3% |
| 2022 | 2 | 28.6% |
| 2023 | 1 | 14.3% |
| 2025partial year | 1 | 14.3% |
Top 11 of 11 technology areas
Overall rank by patents
#35,205
of 49,997 tracked assignees
48.8 out of 100
What to do with this data
Enpress LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.